NCT00481871 2020-01-07Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesAcrotech Biopharma Inc.Phase 1/2 Completed119 enrolled 13 charts
NCT02013362 2017-11-09Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell LymphomaMundipharma K.K.Phase 1/2 Completed25 enrolled